Professional Experience
2024 —current Arbor Biotechnologies
Senior Director, Precision Editing
2021 —2024 Tome Biosciences
2022-2023, Director of Gene Therapy & Founding Head of Platform Innovations
2021-2022, Principal Scientist, RNA Synthetic Biology and Genome Engineering
2020 —2021 Flagship Pioneering (Venture Lab 59, Radial Therapeutics)
Senior Scientist, RNA Targeting Platform R&D
2012 —2022 Harvard Medical School, MGH
2019-2020, Instructor in Medicine (Research Faculty), Epigenetics of Liver Fibrosis
2012-2019, Postdoctoral Fellow, RNA Biology in Pluripotent Stem Cells